Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proassurance (PRA) Other Accumulated Expenses (2016 - 2025)

Proassurance (PRA) has disclosed Other Accumulated Expenses for 15 consecutive years, with $3.0 billion as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 7.35% to $3.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 billion through Dec 2025, down 7.35% year-over-year, with the annual reading at $3.0 billion for FY2025, 7.35% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $3.0 billion at Proassurance, down from $3.1 billion in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $3.6 billion in Q3 2021, with the low at $2.4 billion in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $3.3 billion, with a median of $3.4 billion recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 51.59% in 2021, then fell 7.35% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $3.6 billion in 2021, then decreased by 3.04% to $3.5 billion in 2022, then dropped by 2.01% to $3.4 billion in 2023, then fell by 4.22% to $3.3 billion in 2024, then decreased by 7.35% to $3.0 billion in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $3.0 billion, $3.1 billion, and $3.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.